Biological therapy for pustular psoriasis: a systematic review.

Leyre A Falto-AizpuruaRafael F Martin-GarciaOsward Y CarrasquilloOscar W Nevares-PomalesXavier Sánchez-FloresDeyson Lorenzo-Rios

Published in: International journal of dermatology (2019)

Infliximab and ustekinumab have the most evidence of efficacy and safety for the treatment of pustular psoriasis. Recent evidence supports the use of IL-17 antagonists. Prospective controlled and comparative trials are needed to further explore the efficacy and safety of biologic agents in order to establish objective recommendations for the management of this challenging condition.

Keyphrases

rheumatoid arthritis
clinical practice
ulcerative colitis
patients with inflammatory bowel disease